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 Abstract 
 Background: Circulating cell-free (ccf) DNA in blood has 
been suggested as a potential biomarker in many conditions 
regarding early diagnosis and prognosis. However, misdiag-
nosis can result due to the limited DNA resources in Biobank ’ s 
plasma samples or insuffi cient DNA targets from a predomi-
nant DNA background in genetic tests. This study explored 
several strategies for an effi cient DNA extraction to increase 
DNA amount from limited plasma input. 
 Methods: Ccf plasma DNA was extracted with three different 
methods, a phenol-chloroform-isoamylalcohol (PCI) method, a 
High Pure PCR Template Preparation Kit method and a method 
used for single cell PCR in this group. Subsequently, the total 
DNA was measured by Nanodrop and the genome equivalents 
(GE) of the  GAPDH housekeeping gene and  MTATP  8 gene 
were measured using a multiplex real-time quantitative PCR 
for the quantitative assessment of nDNA and mtDNA. 
 Results:  Instead of 400 – 800  μ L (routine input in the labora-
tory), 50  μ Lof plasma input enabled the extraction of ccf DNA 
suffi cient for quantitative analysis. Using the PCI method and 
the kit method, both nDNA and mtDNA could be successfully 
detected in plasma samples, but nDNA extracted using proto-
col for single cell PCR was not detectable in 25 % of plasma 
samples. In comparison to the other two methods, the PCI 
method showed lower DNA purity, but higher concentrations 
and more GE of nDNA and mtDNA. 
 Conclusions: The PCI method was more effi cient than the 
other two methods in the extraction of ccf DNA in plasma. 
Limited plasma is available for ccf DNA analysis. 
 Keywords:  circulating cell-free DNA;  mitochondrial DNA; 
 nuclear DNA. 
 Introduction 
 Circulating cell-free (ccf) DNA in blood has been sug-
gested as a potential biomarker for many conditions  (1, 2) . 
Quantitative and qualitative assessments of ccf DNA in 
plasma are gaining increasing importance as tools for blood-
based diagnosis and monitoring varieties of diseases  (3 – 5) . 
The quantitative changes, such as nuclear DNA (nDNA) and 
mitochondrial DNA (mtDNA) and qualitative changes, such 
as tumor-specifi c methylated DNA, viral DNA, microsatellite 
alterations and oncogene mutations were observed in plasma 
and serums of various conditions. Ccf DNA assessments offer 
a high diagnostic specifi city in cancer, pathological pregnan-
cies, infl ammatory diseases, trauma and transplant graft rejec-
tion  (6 – 11) . This might become a valuable prognostic marker 
providing the possibility of examining diseases from genetic 
materials in the circulation. Thus, the quantitative and quali-
tative assessments of ccf DNA are important tools for diag-
nosing and tracking the diseases and their progressions. 
 However, there were many problems faced in extracting ccf 
DNA from plasma. Firstly, there are no commercially avail-
able extraction kits intended for ccf DNA and especially the 
special genes in plasma; therefore, the extraction kits for whole 
blood DNA were often used instead. Furthermore, the con-
centrations of ccf DNA reportedly vary from 6 to 650 ng/mL 
approximately in the plasma of healthy men  (12, 13) . The 
wide range and low concentrations suggest that the currently 
performed DNA extraction method is not ideal for analysis of 
ccf DNA. Since a standard method for extracting ccf DNA in 
the plasma does not exist, further studies and clinical applica-
tions of ccf DNA were limited. 
 Another problem encountered was the limited DNA 
resources and the minute amounts of DNA targets which 
hindered the detection of target genes at suffi cient amounts. 
Since the levels of ccf DNA in plasma varies depending on 
diseases, the more quantitative and qualitative assessments of 
ccf DNA investigated the better the analysis of relating ccf DNA 
to specifi c diseases. Therefore, more DNA targets and more 
plasma were needed for genetic tests. However, valuable plasma 
or serum samples from Biobank are normally limited and orders 
are in quantities insuffi cient for DNA extraction. Moreover, this 
led to inaccuracies when conducting qualitative assessments 
of ccf DNA which can easily lead to misdiagnosis, especially 
when very low concentrations of DNA targets are observed 
in the case of tumor DNA, fetal DNA and oncogene mutations. 
 The aim of this study was to explore an effi cient method of 
extracting ccf DNA for further analysis of ccf DNA. We com-
pared the quantifi cation of total DNA, nDNA and mtDNA 
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extracted in plasma by three different methods: the column 
kit method, the phenol-chloroform-isoamylalcohol (PCI) 
method and the method used for single cell PCR successfully 
to amplify genes from single cell. The three methods were 
used to select an optimal ccf DNA extraction for reducing 
input sample volume while increasing the extracted DNA 
concentration necessary for ccf DNA analysis. The concen-
tration of ccf DNA was measured by Nanodrop and the GE 
of the  GAPDH housekeeping gene and  MTATP 8 gene were 
measured using a multiplex real-time quantitative PCR for 
the quantifi cation of nDNA and mtDNA, which was success-
fully developed in our laboratory  (14) . 
 Materials and methods 
 Sample collection 
 The plasma samples used in this study were obtained from the 
Biobank of Basel University Hospital. Blood samples were collect-
ed into tubes containing EDTA-K 3 as anticoagulant and processed 
within 2 h after vein-puncture. Subsequently, they were processed 
immediately by centrifugation at 1600 × g for 10 min. The plasma 
layer was transferred to a new Eppendorf tube and centrifuged again 
at maximum speed (16,000 × g ) for 10 min. Plasma samples were 
divided into aliquots of 400  μ L each and stored at  – 80 ° C. The study 
was approved by the Local Ethic Committees. 
 DNA extraction 
 The extractions of ccf DNA in 20 plasma samples were conducted 
using three protocols: the PCI method, High Pure PCR Template 
Preparation Kit (Roche) method and the method used for single cell 
PCR. The PCI method is an organic solvent extraction-based DNA 
preparation  (15) ; 50  μ L plasma was diluted into 550  μ L water and an 
equal volume of PCI (25:24:1) was added. The mixture was centri-
fuged at top speed for 1 – 2 min to separate the phases. Subsequently, 
the aqueous phase was moved to a new tube with two volumes of 
ice-cold 100 % ethanol to precipitate the DNA. After 1 min full speed 
centrifugation, the supernatant was removed and DNA dissolved in 
12.5  μ L tris-EDTA buffer. The ccf DNA of the second aliquot was 
extracted using a High Pure PCR Template Preparation Kit, which 
was a silica-based column DNA preparation and performed accord-
ing to the kit instrument. The extracted DNA from 200  μ L plasma 
was dissolved in 50  μ L tris-EDTA buffer. For the third aliquot, the 
protocol for single cell PCR was used  (16) . Ccf DNA was extracted, 
amplifi ed and quantifi ed in the same tube; 5  μ L plasma was added 
to a PCR tube containing 7.5  μ L of 400 ng/ μ L Proteinase K and 
17  μ mol/L sodium dodecyl sulfate. The solution was incubated at 
50 ° C for 1 h, followed by 99 ° C for 30 min to extract DNA, degrade 
protein and use for quantitative analysis. 
 Total DNA quantitative determinations 
 The concentrations of different DNA dilutions were detected by 
a Nanodrop 1000 spectrophotometer (Thermo Scientifi c) fi rstly. 
Because the composition and quality of ccf DNA were unidenti-
fi ed, the multiplex real-time PCR was conducted subsequently. The 
ccf DNA extracted by protocol for single cell PCR was mixed by 
proteins and amplifi ed by real-time PCR directly; therefore, its con-
centration was not measured. 
 Amplifi cation and quantifi cation of nDNA 
and mtDNA in plasma samples 
 Real-time PCR assays are widely used for quantitative assessment of 
DNA in plasma or serum because it is shown to be simple and robust 
with a detection limit of about 1 ng/mL and high inter-assay reliabil-
ity  (17) , but the spectrophotometric measurements were not suitable 
for such minute quantities of DNA in plasma  (5) . Therefore, the GE 
of nDNA and mtDNA were assessed with the multiplex real-time 
PCR. This process could perform two assays in a single tube at the 
same time and be an effi cient and accurate method for quantifying 
the ccf nDNA and mtDNA  (14) . 
 A total of 5  μ L of DNA dilution was used as a template for the 
TaqMan real-time PCR analysis by an ABI PRISM 7000 Sequence 
Detection System (Applied Biosystems, ABI). The amount of nDNA 
was quantifi ed using the following primer pairs and VIC-labeled 
TaqMan MGB-probe for the  GAPDH housekeeping gene. The prim-
ers were 5-CCC CAC ACA CAT GCA CTT ACC-3 (forward primer) 
and 5-CCT AGT CCC AGG GCT TTG ATT-3 (reverse primer) and 
the probe was 5-(MGB) TAG GAA GGA CAG GCA AC (VIC)-3. 
For determining mtDNA, a sequence of the  MTATP  8 gene starting 
at locus 8446 was amplifi ed and quantifi ed. The primers were 5-AAT 
ATT AAA CAC AAA CTA CCA CCT ACC-3 (forward primer) and 
5-TGG TTC TCA GGG TTT GTT ATA-3 (reverse primer) and the 
probe was 5-(FAM) CCT CAC CAA AGC CCA TA (MGB)-3. The 
multiplex real-time PCR was performed in a total reaction volume of 
25  μ L, containing 5  μ L of DNA, 12.5  μ L of TaqMan Universal PCR 
Master Mix, four primers and two probes. Our standard TaqMan 
PCR conditions have been described in our previous publication 
 (14) , which involved a 2 min incubation at 50 ° C, followed by an 
initial denaturation step at 95 ° C for 10 min and 40 cycles of 1 min at 
60 ° C and 15 s at 95 ° C. 
 A standard curve of a diluted DNA, one negative control and one 
calibrator DNA, were included in each run. The concentrations of ccf 
nDNA were estimated according to the standard curves and drawn 
using the known concentration of human genomic DNA. The con-
centrations of ccf nDNA were expressed as GE per mL of plasma 
 (18) . Relative quantities of ccf mtDNA could be estimated using fold 
change of GE 
nDNA and also expressed as GE per mL of plasma. 
 Statistical analysis 
 In all cases, experiments were replicated in triplicate and data was 
presented as median, range and fold change and analyzed with the 
SPSS software. The Wilcoxon, Mann-Whitney and Kruskal-Wallis 
tests were used to compare the amounts of ccf DNA in different groups 
categorized by PCI method, kit method and protocol for single cell 
PCR. A p-value below 0.05 was considered statistically signifi cant. 
 Results 
 Total DNA quantitative determinations 
 The purity and concentration of DNA dilution extracted by 
two different protocols were different. The ratio of 260/280 
of DNA dilution extracted by kit was higher than that by PCI 
method (1.65 ± 0.15 vs. 1.06 ± 0.21). However, the concentra-
tion was less than that by PCI method (23.91 ± 8.82 ng/mL 
vs. 407.32 ± 239.36 ng/mL). Because the DNA extracted by 
protocol for single cell PCR was amplifi ed directly, the con-
centration and purity of DNA were not investigated. 
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 Amplifi cation and quantifi cation of nDNA 
and mtDNA in plasma samples 
 Ccf DNA extracted by three different methods was amplifi ed, 
quantifi ed and subsequently compared for the differences in the 
quantifi cation of nDNA and mtDNA. Using the PCI method 
and kit method for DNA extraction, both nDNA and mtDNA 
were successfully detected in plasma samples; mtDNA was also 
successfully detectable with the protocol for single cell PCR, 
while nDNA was not in 25 % of plasma samples. The standard 
curves using a known concentration of human genomic DNA 
containing six concentration points for both mtDNA and nDNA 
are shown in Figure  1 . The average slope of standard curve 
of mtDNA or nDNA was approximately  – 3.3 (nearly 100 % 
effi ciency) in multiplex real-time PCR. 
 The ccf DNA equivalents in the paired plasma samples were 
determined by multiplex real-time PCR, calculated according 
to the standard dilution curves, expressed as GE/mL, and shown 
in Table  1 . The GE of nDNA and mtDNA extracted by PCI 
were greater than that by kit, respectively, (9094.84 GE/mL vs. 
4498.81 GE/mL, 119315.70 GE/mL vs. 21741.76 GE/mL), in 
the plasma, although a lower volume of plasma was used (50  μ L 
vs. 200  μ L). The GE of mt DNA extracted by PCI method was 
approximately 5.5-fold and the GE of nDNA was approximately 
2-fold of the kit method. By the protocol of single cell PCR, the 
mtDNA could be detectable in all samples (1647.06 GE/mL), 
with the nNDA in 75 % of the samples (525.45 GE/mL). The 
examples of amplifi cation curves of mtDNA extracted by three 
methods were shown in Supplementary Figure  1 . The cycle 
threshold (Ct) value of mtDNA extracted by the PCI method 
was less than that by the kit method. 
 Discussion 
 In this study, we aimed to explore an effi cient method to 
extract the ccf DNA in limited plasma samples. Three methods 
for extracting DNA were involved. Although the PCI method 
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 Figure 1  Multiplex real-time PCR kinetics for amplifying mtDNA 
and nDNA on serial dilutions. 
 The fi gure shows reproducible standard dilution curves for identifi -
cation of the mtDNA and nDNA. The standard curves with average 
slopes was approximately  – 3.3 (nearly 100 % effi ciency) in multiplex 
real-time PCR. 
provided less purity, the concentration of ccf DNA measured 
by Nanodrop was more than that by the kit method. The 
260/280 ratio of ccf DNA extracted by the PCI method was 
less than that by the kit method. This indicated that there might 
be contamination of residual ethanol, protein and others in the 
dilution extracted by PCI method. It might be easier to get 
contamination with the PCI method while removing the aque-
ous phase containing the DNA to a new tube. However, the kit 
could bind nucleic acids with column and remove contamina-
ting components in a series of rapid  “ wash and spin ” steps. 
Therefore, it had a better purity but might lose some unbound 
DNA. Considering the contamination in the DNA dilutions, 
the result that the concentration of ccf DNA extracted by PCI 
method was more than that by kit method might not prove 
convincing. Thus, the genome equivalents, the quantifi cation 
of nDNA and mtDNA were conducted subsequently. 
 The results of quantifying nDNA and mtDNA showed that 
the GE of ccf mtDNA extracted by PCI method were greater 
in number and that the mtDNA: nDNA ratio determined of the 
PCI method group was also higher than that of the kit group, 
although there was not any statistical differences between 
the two methods when comparing their GE of nDNA. These 
results indicated that the column isolation by kit might reduce 
total ccf DNA in ways that wasted more mtDNA than nDNA. 
This could cause the under-estimation of the GE of mtDNA. 
Most column DNA extraction kits rely on high concentrations 
of chaotropic salts and low pH to extract DNA because the 
negatively-charged DNA phosphate backbones could bind to 
positively-charged silica gel beads. However, the salt concen-
trations, pH, fat and wash buffer ethanol contents could infl u-
ence DNA binding in a size-dependent manner  (15, 19) . The 
column kits were optimized for the isolation of DNA fragments 
by more than 50 Kb  (20) . Moreover, the RNAase contained in 
the column kits could minimize the quantity of mtDNA  (15) . 
Thus, the column kits seemed unsuitable for mtDNA quantifi -
cation but did not affect nDNA quantifi cation. This also might 
be the reason for the wide range of quantitative assessments 
discussed in the previous papers, i.e., the mean ccf DNA con-
centrations of 6 – 20 ng/mL or 650 ng/mL were measured in 
the plasma of healthy men by different methods  (2) . 
 The PCI method could provide a high ccf DNA capture 
effi ciency, though more time-consuming and subject to vari-
able technical prowess. It was less dependent on DNA size 
and enabled more accurate assessment of small size DNA, 
like mtDNA. Since ccf DNA consists of fractions of differ-
ent sizes  (21) , using isolation methods that capture all of the 
DNA fractions is of the utmost importance for the reliability 
of all downstream experiments and their comparability  (22) . 
Therefore, the PCI method seems to be preferable in captur-
ing and isolating of mtDNA. Although that insuffi cient phenol 
could cause oxidation and contaminants of residual ethanol, 
proteins and divalent cations might inhibit PCR, the amplifi -
cation effi ciency of nDNA and mtDNA were nearly 100 % and 
the GE of ccf DNA extracted by PCI was still higher in the 
study. Moreover, the DNA extracted by the PCI method could 
be concentrated by decreasing the volume of dissolved buffer 
while the test kit method does not allow all of the DNA 
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 Table 1  Circulating cell-free mtDNA and nDNA extracted by three different methods. 
Sample nDNA, GE/mL mtDNA, GE/mL
PCI method Kit method Single cell PCR PCI method Kit method Single cell PCR
  1 4295.94 20,239.84 525.45 30,759.80 58,856.34 5139.51
  2 7737.59 2562.57 166.69 59,792.12 8800.53 3931.89
  3 2958.04 5140.07 75.70 20,177.02 24,620.50 362.60
  4 11,564.47 1751.88 93.88 128,144.40 7355.91 408.11
  5 18,569.92 3857.55 1335.58 147,533.20 725.82 1401.98
  6 8078.00 3110.42 Undetectable 119,759.70 569.24  576.83
  7 3539.28 399.50 Undetectable 28,511.16 11,129.20 1779.62
  8 11,731.63 1678.05 192.41 247,679.70 39,309.04 1550.01
  9 1268.43 154.94 Undetectable 65,938.06 1579.80 139.31
10 462,349.60 24,566.92 932.93 5724,129.00 1259,508.00 12,639.23
11 8931.70 3439.13 1252.05 173,517.20 31,604.21 7913.36
12 43,932.05 21,130.30 3946.85 415,067.50 18,912.15 21,269.29
13 585,885.40 294,195.10 1364.64 2825,861.00 352,292.40 43,067.32
14 11,481.78 29,184.01 149.68 75,650.31 30,213.19 840.86
15 9257.98 12,695.19 Undetectable 29,460.24 4744.35 261.96
16 5724.21 1030.12 236.92 121,690.80 21,153.37 1744.12
17 14,654.39 11,399.68 164.31 118,871.70 22,330.16 385.42
18 3775.40 2454.58 Undetectable 15,526.15 3471.30 313.44
19 6283.90 25,464.36 1279.30 70,603.09 35,270.93 17,093.18
20 380,914.00 38,608.75 4790.64 3026,262.00 484,669.00 335,511.70
Median 
and range
9094.84 
(525.45 – 4498.81)
4498.81 
(154.94 – 294,195.10)
25.45 a 
(75.70 – 4790.64)
119,315.70 
(15,526.15 – 5724,129.00)
21,741.76 a 
(569.24 – 1259,508.00)
1647.06 a 
(139.31 – 335,511.70)
 
a
 Statistical signifi cances between the method and PCI method (p < 0.05); mtDNA, mitochondrial DNA; nDNA, nuclear DNA; PCI method, 
phenol-chloroform-isoamylalcohol method; kit method, High Pure PCR Template Preparation Kit (Roche) method. 
binding to columns to be washed down with fewer 
volumes of dissolved buffers. 
 The single cell PCR was a very sensitive method, but 
little contamination could verify the results  (16) . By using 
only 5  μ L volume of plasma, the mtDNA was detectable, but 
the concentration of mtDNA was less than that of the PCI 
method. This indicated that the DNA in the action tube might 
be combined or broken down by the contaminants, because all 
the salts and proteins in the plasma were put in the detection 
system. Moreover, because the nDNA was less than mtDNA, 
it can be detectable only in 75 % of samples. Also, the input 
volume of plasma was limited by the size of tube, therefore, 
the improvement of detection sensitivity of nDNA by increas-
ing input of plasma might not be feasible. 
 Increased clinical importance of ccf DNA was found not 
only for the diagnosis, prediction and prognosis of varied dis-
eases but also for monitoring patients in disease surveillance 
and during treatment. As result, effi cient isolation procedures 
of ccf DNA and sensitive determination procedures were 
demanded. The PCI method demonstrated higher effi ciency in 
extracting of ccf DNA and can be an important procedure for 
detecting the quantitative and qualitative change of ccf DNA 
in limited DNA resource and targets. The PCI method needed 
only 50  μ L plasma and could gain more concentration and 
genome equivalents of DNA dilution by column kit method 
which used 200  μ L plasma. Although the protocol for single 
cell PCR uses even less plasma, it was not as sensitive as 
the PCI method due to the inhibition of protein or salt. Thus, 
the PCI method might be considered a suitable approach for 
extracting ccf DNA in plasma. 
 Acknowledgments 
 This work was supported by China Scholarship Council. We are 
grateful to Matt Ji for proofreading the manuscript. We thank Vivian 
Kiefer, Corina Kohler, Zeinab Barekati and Hongbo Chen for their 
kind assistance. 
 Confl ict of interest statement 
 Authors ’ confl ict of interest disclosure: The authors stated that 
there are no confl icts of interest regarding the publication of this 
article. Research support played no role in the study design; in the 
collection, analysis and interpretation of data; in the writing of the 
report; or in the decision to submit the report for publication. 
 Research funding: None declared. 
 Employment or leadership: None declared. 
 Honorarium: None declared. 
 References 
 1.  Sozzi G, Conte D, Leon M, Ciricione R, Roz L, Ratcliffe C, et al. 
Quantifi cation of free circulating DNA as a diagnostic marker in 
lung cancer. J Clin Oncol 2003;21:3902 – 8. 
 2.  Jung K, Fleischhacker M, Rabien A. Cell-free DNA in the blood 
as a solid tumor biomarker  – a critical appraisal of the literature. 
Clin Chim Acta 2010;411:1611 – 24. 
Chen et al.: An effi cient DNA extraction method  265
 3.  Catarino R, Ferreira MM, Rodrigues H, Coelho A, Nogal A, Sousa 
A, et al. Quantifi cation of free circulating tumor DNA as a diag-
nostic marker for breast cancer. DNA Cell Biol 2008;27:415 – 21. 
 4.  Ye L, Ma GH, Chen L, Li M, Liu JL, Yang K, et al. 
Quantifi cation of circulating cell-free DNA in the serum of 
patients with obstructive sleep apnea-hypopnea syndrome. 
Lung 2010;188:469 – 74. 
 5.  Swarup V, Rajeswari MR. Circulating (cell-free) nucleic acids 
– a promising, non-invasive tool for early detection of several 
human diseases. FEBS Lett 2007;581:795 – 9. 
 6.  Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, 
et al. Quantitative analysis of fetal DNA in maternal plasma and 
serum: implications for noninvasive prenatal diagnosis. Am J 
Hum Genet 1998;62:768 – 75. 
 7.  Konorova IL, Veiko NN, Ershova ES, Antelava AL, Chechetkin 
AO. Haemodynamic role of blood-plasma circulating cell-free 
DNA and contained therein high-molecular-weight CpG-rich 
fraction in pathogenesis of arterial hypertension and athero-
sclerosis obliterans of carotid arteries. Angiol Sosud Khir 2009;
15:19 – 28. 
 8.  Allen D, Butt A, Cahill D, Wheeler M, Popert R, Swaminathan 
R. Role of cell-free plasma DNA as a diagnostic marker for pros-
tate cancer. Ann NY Acad Sci 2004;1022:76 – 80. 
 9.  Lam NY, Rainer TH, Chiu RW, Joynt GM, Lo YM. Plasma 
mitochondrial DNA concentrations after trauma. Clin Chem 
2004;50:213 – 6. 
 10.  Zhong XY, von Muhlenen I, Li Y, Kang A, Gupta AK, Tyndall A, 
et al. Increased concentrations of antibody-bound circulatory cell-
free DNA in rheumatoid arthritis. Clin Chem 2007;53:1609 – 14. 
 11.  Lo YM, Tein MS, Pang CC, Yeung CK, Tong KL, Hjelm NM. 
Presence of donor-specifi c DNA in plasma of kidney and liver-
transplant recipients. Lancet 1998;351:1329 – 30. 
 12.  Altimari A, Grigioni AD, Benedettini E, Gabusi E, Schiavina 
R, Martinelli A, et al. Diagnostic role of circulating free plasma 
DNA detection in patients with localized prostate cancer. Am J 
Clin Pathol 2008;129:756 – 62. 
 13.  Chun FK, Muller I, Lange I, Friedrich MG, Erbersdobler A, 
Karakiewicz PI, et al. Circulating tumour-associated plasma 
DNA represents an independent and informative predictor of 
prostate cancer. Br J Urol Int 2006;98:544 – 8. 
 14.  Xia P, Radpour R, Zachariah R, Fan AX, Kohler C, Hahn S, 
et al. Simultaneous quantitative assessment of circulating cell-
free mitochondrial and nuclear DNA by multiplex real-time 
PCR. Genet Mol Biol [online] 2009;32:20 – 4. 
 15.  Guo W, Jiang L, Bhasin S, Khan SM, Swerdlow RH. DNA extrac-
tion procedures meaningfully infl uence qPCR-based mtDNA 
copy number determination. Mitochondrion 2009;9:261 – 5. 
 16.  Troeger C, Zhong XY, Burgemeister R, Minderer S, Tercanli S, 
Holzgreve W, et al. Approximately half of the erythroblasts in 
maternal blood are of fetal origin. Mol Hum Reprod 1999;5:
1162 – 5. 
 17.  Szpechcinski A, Struniawska R, Zaleska J, Chabowski M, 
Orlowski T, Roszkowski K, et al. Evaluation of fl uorescence-
based methods for total vs. amplifi able DNA quantifi ca-
tion in plasma of lung cancer patients. J Physiol Pharmacol 
2008;59(Suppl 6):675 – 81. 
 18.  Zhong XY, Hahn S, Kiefer V, Holzgreve W. Is the quantity of 
circulatory cell-free DNA in human plasma and serum samples 
associated with gender, age and frequency of blood donations ? 
Ann Hematol 2007;86:139 – 43. 
 19.  Aplenc R, Orudjev E, Swoyer J, Manke B, Rebbeck T. Differential 
bone marrow aspirate DNA yields from commercial extraction 
kits. Leukemia 2002;16:1865 – 6. 
 20.  Carter MJ, Milton ID. An inexpensive and simple method 
for DNA purifi cations on silica particles. Nucleic Acids Res 
1993;21:1044. 
 21.  Liu KJ, Brock MV, Shih Ie M, Wang TH. Decoding circulating 
nucleic acids in human serum using microfl uidic single molecule 
spectroscopy. J Am Chem Soc 2010;132:5793 – 8. 
 22.  Wang M, Block TM, Steel L, Brenner DE, Su YH. Preferential 
isolation of fragmented DNA enhances the detection of circulat-
ing mutated k-ras DNA. Clin Chem 2004;50:211 – 3. 
